Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Researchers find cancer-inhibiting compound under the sea

Researchers find cancer-inhibiting compound under the sea

August 11, 2008

GAINESVILLE, Fla. - University of Florida College of Pharmacy researchers have discovered a marine compound off the coast of Key Largo that inhibits cancer cell growth in laboratory tests, a finding they hope will fuel the development of new drugs to better battle the disease.

The UF-patented compound, largazole, is derived from cyanobacteria that grow on coral reefs. Researchers, who described results from early studies today (Aug. 7) at an international natural products scientific meeting in Athens, Greece, say it is one of the most promising they've found since the college's marine natural products laboratory was established three years ago.




An initial set of papers in the Journal of the American Chemical Society also has garnered the attention of other scientists, and the lab is racing to complete additional research. The molecule's natural chemical structure and ability to inhibit cancer cell growth were first described in the journal in February and the laboratory synthesis and description of the molecular basis for its anticancer activity appeared July 2.

"It's exciting because we've found a compound in nature that may one day surpass a currently marketed drug or could become the structural template for rationally designed drugs with improved selectivity," said Hendrik Luesch, Ph.D., an assistant professor in UF's department of medicinal chemistry and the study's principal investigator.

Largazole, discovered and named by Luesch for its Florida location and structural features, seeks out a family of enzymes called histone deacetylase, or HDAC. Overactivity of certain HDACs has been associated with several cancers such as prostate and colon tumors, and inhibiting HDACs can activate tumor-suppressor genes that have been silenced in these cancers.

Although scientists have been probing the depths of the ocean for marine products since the early 1960s, many pharmaceutical companies lost interest before researchers could deliver useful compounds because natural products were considered too costly and time-consuming to research and develop.

Many common medications, from pain relievers to cholesterol-reducing statins, stem from natural products that grow on the earth, but there is literally an ocean of compounds yet to be discovered in our seas. Only 14 marine natural products developed are in clinical trials today, Luesch said, and one drug recently approved in Europe is the first-ever marine-derived anticancer agent.

"Marine study is in its infancy," said William Fenical, Ph.D., a distinguished professor of oceanography and pharmaceutical sciences at the University of California, San Diego. "The ocean is a genetically distinct environment and the single, most diverse source of new molecules to be discovered."

The history of pharmacy traces its roots back thousands of years to plants growing on Earth's continents, used by ancient civilizations for medicinal purposes, Fenical added. Yet only in the past 30 years have scientists begun to explore the organisms in Earth's oceans, he said. Fewer than 30 labs exist worldwide and research dollars have only become available in the past 15 years.

HDACs are already targeted by a drug approved for cutaneous T-cell lymphoma manufactured by the global pharmaceutical company Merck & Co. Inc. However, UF's compound does not inhibit all HDACs equally, meaning a largazole-based drug might result in improved therapies and fewer side effects, Luesch said.

Since 2006, Luesch and his team of researchers have screened cyanobacteria provided by collaborator Valerie Paul, Ph.D., head scientist at the Smithsonian Marine Station in Fort Pierce. They check the samples for toxic activity against cancer cells and last year encountered one exceptionally potent extract - the one that ultimately yielded largazole.

To conduct further biological testing on the compound, Luesch and his team have been collaborating with Jiyong Hong, an assistant professor in the department of chemistry at Duke University, to replicate its natural structure and its actions in the laboratory.

Luesch said that within the next few months he plans to study whether largazole reduces or prevents tumor growth in mice.

Luesch has several other antitumor natural products from Atlantic and Pacific cyanobacteria in the pipeline.

"We have only scratched the surface of the chemical diversity in the ocean," Luesch said. "The opportunities for marine drug discovery are spectacular."

University of Florida



Related Cancer Cell Growth Current Events and Cancer Cell Growth News Articles Cancer Cell Growth Current Events and Cancer Cell Growth News RSS Cancer Cell Growth Current Events and Cancer Cell Growth News RSS
A new Eph receptor tyrosine kinase overexpressed in gastric cancer was found
The potential role of Eph receptor and ephrin ligand family in human cancer is receiving increasing attention. Compared with other Eph receptors, EphA4 is distinguished by its ability to bind to both type A ephrins and most type B ephrins.

Duke chemists synthesize promising anti-cancer product
Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected.

Fruit fly protein acts as decoy to capture tumor growth factors, find Penn researchers
Researchers at the University of Pennsylvania School of Medicine have shown how Argos, a fruit fly protein, acts as a ¡¥decoy' receptor, binding growth factors that promote the progression of cancer.

Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
An herb used in traditional medicine by many Middle Eastern countries may help in the fight against pancreatic cancer, one of the most difficult cancers to treat.

Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center.

Synergistic growth inhibitory effect of herbal extracts against HCC and lung cancer cells
Several herbs with diversified pharmacological properties are known to be rich sources of chemical constituents that may have potential for the treatment of several human cancers. Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, demonstrates that the growth inhibitory activity of doxorubicin or cisplatin, as single agents, may be modified in combination with emblic myrobalan or belleric myrobalan extracts and may be synergistically enhanced in some cases.

Mayo Clinic identifies treatment target for liver cancer recurrence and survival
Deadly and difficult to treat, liver cancer has long resisted attempts by researchers to develop ways to prolong life and prevent recurrence.

Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.

Cancer stem cells: know thine enemy
Stem cells -- popularly known as a source of biological rejuvenation -- may play harmful roles in the body, specifically in the growth and spread of cancer.

Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer
A new development in the fight against cancer: Recent research at the University of Haifa found that molecules found in common fungus Ganoderma lucidum aid in suppressing some of the mechanisms involved in the progression of prostate cancer.
More Cancer Cell Growth Current Events and Cancer Cell Growth News Articles
It's true! Compound in Ginseng could end cancer.(algycon sapogenins prevent cancer cell growth): An article from: Women's Health Letter

This digital document is an article from Women's Health Letter, published by Soundview Publications on March 1, 2003. The length of the article is 1909 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Biology and Biochemistry of Normal and Cancer Cell Growth (Ettore Majorana International Life Sciences)
by L. Castagnetta

Hormone-Related Tumors: Novel Approaches to Prevention and Treatment (Annals of the New York Academy of Sciences, V. 963)
by Italy) Course of "Biology and Biochemistry of Normal and Cancer Cell Growth" (6th : 2001 : Erice, Luigi Castagnetta

This volume covers the biology and biochemistry of normal and cancer cell growth exhibited in a range of cancers including those of the liver, colorectum, breast, and prostate, and leukemia. Studies include the epidemiology, risk factors, and natural histories of these cancers. Different treatment modalities for various cancers are also...

Bridging the gap: with a boost from the NRC, a small biotech company called PharmaGap limits the growth of cancer cells through gap junction modulation. ... An article from: Canadian Chemical News
by Jeff Pappone

This digital document is an article from Canadian Chemical News, published by Chemical Institute of Canada on May 1, 2003. The length of the article is 1456 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Growth, Cancer, and the Cell Cycle: The Molecular, Cellular, and Developmental Biology
by Philip Skehan

Growth of Cancer Cells
by E.H. Cooper

Nucleic Acid Metabolism Cell Differentiation and Cancer Growth
by Edmund V. Cowdry, Satimaru Seno

Molecular biology and differentiation of cancer cells (oncogenes, growth factors, receptors) (Lectures and symposia of the 14th International Cancer Congress, Budapest, August 21-27, 1986)

Tenascin: An Extracellular Matrix Protein in Cell Growth, Adhesion and Cancer (Molecular Biology Intelligence Unit)
by Prashanta Shrestha, Masahiko Mori

Tenascin, a recently characterized extracellular matrix (ECM) protein which is expressed during embryonic and fetal development, wound healing and various benign and malignant tumors (but highly restricted in normal adult tissues) is believed to affect a number of cellular functions such as cellular growth, differentiation, adhesion and motility. It has been extensively studied in recent years to...

Can strong magnetic fields influence the growth of cancer cells? (Preprint)
by Friedwardt Winterberg

© 2008 BrightSurf.com